Wave Life Sciences

$9.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.45 (+4.78%) As of 4:44 PM UTC today

Why Robinhood?

You can buy or sell WVE and other stocks, options, and ETFs commission-free!

About WVE

Wave Life Sciences Ltd. Ordinary Shares, also called Wave Life Sciences, is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore. The listed name for WVE is Wave Life Sciences Ltd. Ordinary Shares.

CEO

Paul B. Bolno

Employees

301

Headquarters

Singapore, Central Singapore

Founded

2012

Market Cap

504.86M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

455.63K

High Today

$10.03

Low Today

$9.25

Open Price

$9.49

Volume

158.66K

52 Week High

$19.98

52 Week Low

$6.61

Analyst Ratings

50%

of 8 ratings

Buy

50%

Hold

50%

Sell

WVE Earnings

-$1.65

-$1.10

-$0.55

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Mar 4, Pre-Market